Other Liabilities, Noncurrent of Enlivex Therapeutics Ltd. from 31 Dec 2017 to 30 Jun 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary: Enlivex Therapeutics Ltd. quarterly Other Liabilities, Noncurrent in USD history and change rate from 31 Dec 2017 to 30 Jun 2025.
Enlivex Therapeutics Ltd. Other Liabilities, Noncurrent for the quarter ending 30 Jun 2025 was $216,000, a 57% decline year-over-year.
Source SEC data: View on sec.gov

Other Liabilities, Noncurrent, Quarterly (USD)

Other Liabilities, Noncurrent, YoY Quarterly Change (%)

Enlivex Therapeutics Ltd. Quarterly Other Liabilities, Noncurrent (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2025	$216,000	-$283,000	-57%	30 Jun 2025	6-K	29 Aug 2025	2025	Q2
Q4 2024	$299,000	-$387,000	-56%	31 Dec 2024	6-K	29 Aug 2025	2025	Q2
Q2 2024	$499,000			30 Jun 2024	6-K	30 Aug 2024	2024	Q2
Q4 2023	$686,000	-$3,508,000	-84%	31 Dec 2023	20-F	30 Apr 2025	2024	FY
Q4 2022	$4,194,000			31 Dec 2022	20-F	30 Apr 2024	2023	FY
Q4 2018	$192,000	-$152,000	-44%	31 Dec 2018	20-F	30 Apr 2020	2019	FY
Q4 2017	$344,000			31 Dec 2017	20-F	30 Apr 2019	2018	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.